for definite or classical rheumatoid arthritis. Of these, seven were patients with Felty's syndrome. The third group of 39 patients with miscellaneous disorders included eight patients with Raynaud's phenomenon, five with progressive systemic sclerosis, five with myasthenia gravis, x four with Sjogren's syndrome, three with a chronic biological false positive test for syphilis, three with hepatocellular disease, and eleven with unrelated disorders.
TImmunofluorescent Assay for Antinuclear Factors (ANF).
-This was performed by the method of Holborow, Weir, and Johnson (1957) , using frozen 4t-thick sections of mouse liver as nuclear substrate and rabbit antiserum to human F-Il gamma globulin, conjugated with fluorescein as indicator. Each serum containing ANF was tested undiluted and at dilutions of 1: 10 and 1: 100. All sera and dilutions were coded and slides were arranged in random order before fluorescent microscopy (320 x magnification).
Studies with 2-Mercaptoethanol.-Sera from 47 of the patients with SLE and 33 of those with rheumatoid arthritis were also studied after treatment with 2-mercap- The first two of these possibilities represent common phenomena in immunological assays, representing variation in the serum concentration of antibody. The emergence of new immunofluorescent staining types with serum dilution was a more surprising finding. As seen in Table III , all three types of nuclear immunofluorescence demonstrated this finding as serum was diluted. This was, however, Sensitivity of Antinuclear Fluorescence to 2-mercaptoethanol Sera from 47 patients with SLE and 33 with rheumatoid arthritis were examined before and after treatment with 2-mercaptoethanol (ME)*. ME-sensitive ANF occurred both in patients with SLE and in those with rheumatoid arthritis (Table  IV) . However, 21 per cent. (7/33) of those with *The effectiveness of ME-treatment in abolishing activity of 19S immunoglobulin is supported by the following observations:
(1) Serum from a patient with rheumatoid arthritis whose ANF activity was completely abolished by treatment with ME was subjected to gel filtration on a Sephadex G-200 column. Before ME treatment, ANF was found only in the macroglobulin peak, further defined as IgM by Ouchterlony gel diffusion. (2) Rheumatoid factor was determined by the latex fixation technique of Singer and Plotz (1956) using human F-IL gamma-globulin as antigen. Treatment of serum with ME resulted in loss of rheumatoid factor activity from all those sera which originally contained it. (Table VI) .
In our patients, homogeneous fluorescence occurred in a significant number of sera in all clinical groups. Like Beck (1961, 1963) , we found homogeneous staining to be the most frequent type of Beck (1963) , Sj6gren's syndrome. The almost complete specificity of speckling for systemic sclerosis observed by Burnham and others, (1966) was not confirmed. However, as suggested by these authors, such a discrepancy between their observations and the reports of others might result from differences in the definition of speckled fluorescence.
Peripheral immunofluorescence has been reported to occur solely (Gonzalez and Rothfield, 1966) or predominantly (Casals and others, 1963) in patients with systemic lupus. Such a striking association was not apparent in our sera. While peripheral immunofluorescence did represent the most frequent type of staining found in our patients with SLE, it was also the most frequent type in the miscellaneous group. Burnham and others (1966) similarly observed peripheral immunofluorescence in all disease groups studied; and Barnett, Ruderman, Jeannet, and Bloch (1966) described the peripheral pattern in their patients with Felty's syndrome.
No instance of nucleolar staining was observed in our patients. Although Burnham and others (1966) found nucleolar staining to be specific for systemic sclerosis, Beck (1963) demonstrated this rare pattern in systemic and discoid lupus, Sjogren's syndrome, and pernicious anaemia also. Thus, it would appear that this immunofluorescent type of staining, like the other more common ones, cannot be considered diagnostically specific.
Among the several variables to be controlled when performing immunofluorescent assays for antinuclear factors is the dilution of serum. Patterns of immunofluorescence not apparent in undiluted sera may appear with dilution. Thus, while more than one type of nuclear immunofluorescence occurred in 59 (40 per cent.) of the 149 positive undiluted sera, when all dilutions were considered 116 (78 per cent.) of the 149 sera produced more than one type of staining. This emergence of new patterns of immunofluorescence with dilution occurred in all clinical groups and with all staining patterns. The explanation for this phenomenon remains unclear.
As noted previously by Beck (1961) , when homogeneous and speckled fluorescence occur in the same undiluted serum, loss of the homogeneous pattern with dilution may allow speckled staining to become clearly visible. This visual masking of one type of fluorescence by another cannot represent the sole explanation, as evidenced by sera which, undiluted, show speckling but with dilution produce the homogeneous or peripheral patterns. While Ritchie, Bayles, and Harter (1965) have reported that 8 per cent. of rheumatoid sera which were negative undiluted became positive after a dilution of 1: 8, sera from more than 1,500 patients with a wide variety of disorders (including rheumatoid arthritis) have been routinely assayed in our laboratory undiluted and at dilutions of 1: 10 and 1: 100 and in no instance has antinuclear factor appeared with dilution in a serum which was negative undiluted.
Finally, immunofluorescent patterns were considered in relation to the immunoglobulin class of antinuclear antibody, using 2-mercaptoethanol as a means of inactivating antibodies of high molecular weight. Mercaptoethanol has been shown completely to inactivate immunoglobulins of the IgM class (Deutsch and Morton, 1957) . While IgG antibody is not affected by treatment with 2-mercaptoethanol, antibody of the IgA class may be altered to a variable degree. Barnett, Condemi, Leddy, and Vaughan (1964) found IgA antinuclear factor activity to be completely or partially destroyed in six of eight so tested. Thus, in the present study, sensitivity of antinuclear factor to inactivation by mercaptoethanol may represent IgM antibody alone or a combination of IgM and IgA antibody. Studies by other groups have failed to demonstrate in sera antinuclear antibody of only the IgA class.
While both mercaptoethanol-sensitive and mercaptoethanol-insensitive antinuclear factors were found in patients with SLE and rheumatoid arthritis, the incidence of mercaptoethanol-sensitive antibody was greater in cases of rheumatoid disease. These findings are consistent with the observations of Weir and Holborow (1962) , using mercaptoethanol dissociation, and Baum and Ziff (1962) , using column chromatography, who also reported an increased incidence of macroglobulin antinuclear antibody in rheumatoid arthritis. Barnett and others (1964) found antinuclear antibody of all three immunoglobulin classes in patients with SLE and rheumatoid arthritis with the mean titre of IgG antibody in rheumatoid arthritis less than its mean titre in SLE. The IgM antibody titres were comparable in the two disease states. These observations further suggest an increased tendency in patients with rheumatoid arthritis to produce antinuclear antibody of the macroglobulin type.
Finally, in the present study, antibody sensitivity to mercaptoethanol was not specific for any pattern of nuclear immunofluorescence, either in patients with systemic or those with rheumatoid arthritis. Gonzales and Rothfield (1966) similarly found homogeneous and speckled staining to be produced equally by the three immunoglobulin classes, in contrast to the observations of Bonomo, Tursi, and Dammacco (1965) who fractionated nine sera by DEAE-cellulose chromatography and found homogeneous nuclear staining related to 7S antibody and speckling associated with antibody in the macroglobulin fraction. In our series, comparing patients with systemic lupus to those with rheumatoid arthritis, homogeneous and speckled patterns sensitive to mercaptoethanol were comparable in frequency. However, a significantly greater proportion of rheumatoid sera producing the peripheral pattern had mercaptoethanol-sensitive antibody. Sensitivity to mercaptoethanol was found in five of the six patients with Felty's syndrome and peripheral staining, but even when these cases are excluded, the observed difference between systemic lupus and rheumatoid disease remains as further evidence supporting the trend in rheumatoid patients towards a macroglobulin antinuclear antibody response to certain, though not all, nuclear antigens. Summary Patterns of nuclear immunofluorescence produced by the sera from 76 patients with systemic lupus erythematosus, 34 with rheumatoid arthritis, and 39 with miscellaneous disorders have been studied.
Homogeneous, peripheral, and speckled patterns occurred singly or in all possible combinations in each of the clinical groups. No instance of nucleolar staining was found.
Serum dilution proved to be a major determinant with respect to the morphology of nuclear immunofluorescence.
Neither the pattern of immunofluorescent staining nor the patient's clinical syndrome was found to correlate specifically with sensitivity of antinuclear antibody to 2-mercaptoethanol. La diluci6n de suero resulto ser un determinante de importancia con respecto a la morfologia de la inmunofluorescencia nuclear.
Se descubrio que ni el esquema de coloracion nmmunofluorescente ni el sindrome clinico del paciente tenian correlaci6n especffica con la sensibilidad del anticuerpo antinuclear al 2-mercaptoetanol. immunofluorescent patterns. 
Significance of nuclear

